Format

Send to

Choose Destination
Biomark Med. 2010 Jun;4(3):465-73. doi: 10.2217/bmm.10.13.

Biomarker use in tailored combat casualty care.

Author information

1
Regenerative Medicine Department, Naval Medical Research Center, 503 Robert Grant Avenue 2W123, Silver Spring, MD 20910, USA.

Abstract

Modern war wounds are complex and primarily involve extremities. They require multiple operative interventions to achieve wound closure and begin rehabilitation. Current assessment of the suitability of surgical wound closure is based upon subjective methods coupled with a semiquantitative determination of the wound bacterial burden. Measurement of the systemic and local response to injury using inflammatory biomarkers may allow for accelerated wound closure and treatment of other combat-related morbidity. This article presents the introduction of personalized medicine into combat casualty care.

PMID:
20550480
DOI:
10.2217/bmm.10.13
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Atypon
Loading ...
Support Center